Attention Deficit Hyperactivity Disorder Clinical Trials in Cincinnati, Ohio

4 studies are recruiting for attention deficit hyperactivity disorder in Cincinnati, Ohio right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation

   The primary purpose of this study is to evaluate the efficacy of centanafadine once daily (QD) extended-release (XR) capsules in adults with attention-deficit/hyperactivity disorder (ADHD) and emotional dysregulation (ED).

   Stage

   Phase 3

   Ages

   18 to 65

   Site

   Patient Priority Clinical Trials, Cincinnati, Ohio

   Locations

   16 in total

   Run by

   Otsuka Pharmaceutical Development & Commercialization, Inc.

   See if you can join NCT07759154 on ClinicalTrials.gov

2. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

   This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD.

   Stage

   Phase 4

   Ages

   4 to 5

   Site

   Cincinnati Children's Hospital and Medical Center, Cincinnati, Ohio

   Locations

   47 in total

   Run by

   Supernus Pharmaceuticals, Inc.

   See if you can join NCT04781140 on ClinicalTrials.gov

3. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

   The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK…

   Stage

   Not phased

   Ages

   0 to 20

   Site

   Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio

   Locations

   52 in total

   Run by

   Duke University

   See if you can join NCT04278404 on ClinicalTrials.gov

4. ADHD PreSMA Response Inhibition Therapy

   ADHD children have abnormal inhibitory control, meaning they have trouble stopping themselves from doing something they should not do. This ability to control involves an area in the brain called the pre-supplementary motor area (pre-SMA). Scientists have previously shown that the pre-SMA is abnorm…

   Stage

   Not phased

   Ages

   12 to 17

   Site

   Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

   Run by

   Children's Hospital Medical Center, Cincinnati

   See if you can join NCT06325813 on ClinicalTrials.gov